Table 3.
Group | β0 | β1 | β2 | P Value for Group Comparison |
---|---|---|---|---|
Glucose Ra | ||||
MEM for control and T1D groups | ||||
Lean control | 2.24 ± 0.36 | −0.27 ± 0.19 | −0.01 ± 0.02 | 0.0044 |
T1D | −0.39 ± 0.84 | 1.10 ± 0.43 | −0.15 ± 0.05 | |
MEM for control and T2D groups | ||||
Lean control | 2.24 ± 0.34 | −0.27 ± 0.18 | −0.01 ± 0.02 | 0.0037 |
T2D | 0.92 ± 1.24 | 0.33 ± 0.56 | −0.05 ± 0.06 | |
MEM for control and obese groups | ||||
Lean control | 2.20 ± 0.37 | −0.24 ± 0.20 | 0.00 ± 0.03 | 0.5519 |
Obese nondiabetic | 1.85 ± 0.76 | −0.05 ± 0.39 | −0.02 ± 0.05 | |
STS models | ||||
Lean control | 0.40 ± 0.35 | −2.36 ± 2.38 | 3.32 ± 3.34 | |
Type 1 diabetes | −2.21 ± 2.78 | 6.57 ± 9.97 | −3.27 ± 8.55 | 0.1204* |
Type 2 diabetes | −2.98 ± 7.62 | 11.17 ± 30.50 | −9.15 ± 29.88 | 0.0875** |
Obese nondiabetic | −0.16 ± 0.63 | −0.77 ± 2.00 | 3.23 ± 1.99 | 0.0579*** |
Glycerol Ra | ||||
MEM for control and T1D groups | ||||
Lean control | 5.95 ± 0.76 | −2.42 ± 0.40 | 0.26 ± 0.05 | 0.2308 |
T1D | 8.66 ± 2.01 | −3.59 ± 1.01 | 0.40 ± 0.12 | |
MEM for control and T2D groups | ||||
Lean control | 5.99 ± 0.58 | −2.44 ± 0.31 | 0.27 ± 0.04 | 0.0194 |
T2D | 2.62 ± 2.19 | −0.58 ± 0.99 | 0.04 ± 0.11 | |
MEM for control and obese groups | ||||
Lean control | 5.95 ± 0.63 | −2.42 ± 0.33 | 0.26 ± 0.04 | 0.1165 |
Obese nondiabetic | 6.73 ± 1.29 | −2.55 ± 0.65 | 0.27 ± 0.08 | |
STS models | ||||
Lean control | 4.52 ± 1.90 | −17.77 ± 7.14 | 18.70 ± 6.78 | |
T1D | 8.76 ± 4.89 | −33.46 ± 16.82 | 33.90 ± 13.69 | 0.0903* |
T2D | 9.09 ± 11.62 | −36.80 ± 44.27 | 38.75 ± 41.53 | 0.2888** |
Obese nondiabetic | 6.63 ± 4.25 | −26.32 ± 16.73 | 27.91 ± 16.29 | 0.1698*** |
Values are estimated means ± SE. P values for quadratic MEM are from likelihood ratio test. P values for quadratic STS models are from multivariate ANOVA.
P value for T1D vs. control;
P value for T2D vs. control;
P value for obese vs. control.